The Team

The Children’s Cancer Therapy Development Institute was created with one aim: to make childhood cancer universally survivable, regardless of diagnosis.

Charles Keller, MD

Charles Keller, MD

Scientific Director and Member

Charles’ research focuses on the development of more effective, less toxic therapies for childhood cancers. His special interest is advanced disease that has spread beyond the initial location of the cancer or which makes the tumor unresectable. Charles has co-chaired the brain tumor developmental therapeutics committee (CNS-DVL) of the Children’s Oncology Group and is a member of the soft tissue sarcoma (STS) committee of Children’s Oncology Group. He has also recently completed a 5-year rotation as a Standing Member of the National Cancer Institute NCI-I Study Section. Charles attended Tulane University where he received a degree in Biomedical Engineering prior to attending Baylor College of Medicine where he received his M.D. degree. After completing his internship and residency in Pediatrics at Texas Children’s Hospital, Charles trained in Pediatric Hematology-Oncology at the University of Utah and with 2007 Nobel laureate, Mario Capecchi. Charles has authored over 100 scientific publications and is a recognized expert in the biology of childhood sarcomas and the preclinical investigation of childhood cancers. Charles is also a co-founder of First Ascent Biomedical, a company* developing personalized medical approaches to therapy for canine and human solid tumor patients. In their spare time, Charles, his wife Kelly & their daughters enjoy outdoor adventures, as well as designing and building treehouses.

* overlap between cc-TDI and FirstAscent is overseen by a conflict of interest management committee.

Guangheng Li, MD, PhD

Guangheng Li, MD, PhD

Assistant Member

GH is the rare surgeon-scientist who impacts musculoskeletal tumor biology in unexpected ways. GH earned his MD from Henan Medical University, Zhengzhou, Henan in 1996. He earned his PhD from Shanghai Second Medical University, Shanghai in 2002, and subsequently trained as a postdoctoral fellow at the University of Pittsburgh and Oregon Health & Science University. Among GH’s key observations are that muscle stem cells (also called ‘satellite cells’) interact with muscle tumor cells (rhabdomyosarcoma). GH began as an Assistant Member at cc-TDI in 2017.

Morgann Turkot, MS

Morgann Turkot, MS

Biomedical Engineering Fellow

Morgann completed her BS and MS in Biomedical Engineering at Northwestern University. While at Northwestern, Morgann worked two years as a student researcher in the laboratory of Dr. Patrick Kiser, focusing on developing drug delivery systems for infectious diseases and women’s health. Morgann specifically worked on projects in formulation science as well as manufacturing and design engineering in order to produce medical devices for long-acting protection against HIV. Morgann joined cc-TDI as a Biomedical Engineering Fellow in July 2016 investigating medulloblastoma, the most common malignant brain tumor in children, with the goal of discovering novel targets and therapies.

Noah E. Berlow, PhD

Noah E. Berlow, PhD

Assistant Member & Information Security Officer

Noah earned his PhD in Electrical Engineering from Texas Tech University under mentor Dr. Ranadip Pal. Noah has previously been a Scott Carter Fellow in the Keller laboratory for a year to facilitate an engineering-biologist collaboration between our labs. His PhD thesis addressed computational & experimental predictions of effective 2-drug combinations for patients with refractory solid tumors (sarcomas), which is work he continues at cc-TDI as an Assistant Member. Noah is also a cc-TDI information security officer. Noah has been a cornerstone scientist of our Engineering Forward initiative. Noah is also a co-founder of First Ascent Biomedical.

* overlap between cc-TDI and FirstAscent is overseen by a conflict of interest management committee.

Megan M. Cleary

Megan M. Cleary

Senior Research Scientist

Megan comes to cc-TDI with four years of experience in the fields of muscle cell and molecular biology, specializing in both the muscle-related pediatric cancer rhabdomyosarcoma and acute myeloid and T-cell leukemia. Her formal education and previous laboratory training provides a strong background in murine muscle dissection and satellite cell/ myoblast isolation and tissue culture, skills which have proved invaluable for studying rhabdomyosarcoma and non-rhabdomyosarcoma soft tissue sarcomas (NRSTS). Megan is adept at performing in vitro molecular biology experiments and GEMM (genetically engineered mouse model) in vivo experiments, both of which are utilized by our laboratory. Megan’slong term research interests include understanding the influence of cell-of-origin on soft tissue sarcoma biology using conditional genetic mouse models.

Narendra Bharathy, PhD

Narendra Bharathy, PhD

Postdoctoral Fellow

Naren completed his MSc in Biotechnology from the University of Madras, then earned his Ph.D. in Physiology from the National University of Singapore (NUS) under mentor, Dr. Reshma Taneja. His Ph.D. thesis, investigating the role of G9a in skeletal muscle differentiation addressed epigenetic factors in muscle stem cells and muscle progenitor cells. His finding was published in Proceedings of the National Academy of Sciences. Naren joined as a postdoctoral fellow at cc-TDI in November 2015. His research work involves investigating the mechanisms of a novel epigenetic therapy for children with muscle cancer (rhabdomyosarcoma). His preclinical investigation of a kinase inhibitor in rhabdomyosarcoma was published recently in Oncotarget. Naren’s previous postdoctoral work with Dr. Taneja also addressed rhabdomyosarcoma and has been published in The Journal of Pathology in 2016. We are privileged to have Naren’s muscle biology and stem cell expertise in our group.

Alexandria Harrold, PhD

Alexandria Harrold, PhD

Postdoctoral Fellow

I first became interested in pediatric neuroscience research as an undergraduate at USC while studying biochemistry and music. Before going to graduate school, I continued working in research, first in a cancer lab and then in a developmental neurobiology lab. I combined these research interests in graduate school at OSHU, where my doctoral research focused on a particular transcription factor, which is known to be involved in numerous pediatric diseases and brain cancer, and understanding how the functions of this protein are controlled. I’m thrilled to be a part of the vibrant team at cc-TDI and to make tangible progress in the treatment of children’s cancers.

Cora Ricker

Cora Ricker

Engineering Fellow

I was originally drawn to cc-TDI after discovering my cousin was diagnosed with stage 4 alveolar rhabdomyosarcoma. In the summer of 2015, I was lucky enough to intern at cc-TDI and study current resources for drug discovery for NF1-associated Pilocytic Astrocytoma (a brain tumor). I graduated from the University of Massachusetts Amherst in Spring 2017 with a chemical engineering degree. My research in the lab centers on the Building Blocks Project.

Samuel Rasmussen, B.Sc.

Samuel Rasmussen, B.Sc.

Engineering Fellow

Samuel began his higher education journey at Mt. Hood Community College while working at John Deere to put himself through school. After finishing the prerequisite courses for Mechanical Engineering he transferred to Portland State University. While at PSU, Samuel conducted an internship at cc-TDI constructing a quail egg ‘opener’ to improve lab efficiency for in vivo drug studies. In December of 2017 Samuel graduated from PSU with a bachelors of science in Mechanical Engineering. He joins cc-TDI as the Macy Easom Foundation Engineering Fellow.

Andy Woods, B.S.

Andy Woods, B.S.

Research Intern & Stella's Dad

Andy’s interest in cancer research stems from his personal experience with childhood cancer. Andy’s oldest daughter is an anaplastic Wilms’ tumor survivor, leading to his interest in helping all children with cancer and a desire to make a mid-life career transition into cancer research. He is passionate about pursuing new preclinical research demonstrating more promising and less toxic treatment strategies for children with cancer and helping to make these treatments available to pediatric cancer patients in the clinical setting.

Christina Luethe

Christina Luethe

Operations Director 

Christina is a self-described adventurer. After attending University of Maryland in Wurzburg, Germany, she returned to Oregon to obtain a BS in Social Science with a minor in Geology. Christina worked for 10 years at the International Animal Semen Bank, notably opening the first ever Canine Semen Cryogenics Bank in Gijon, Spain and in Trinidad. Christina’s roles included teaching and training veterinary clinics in surgical and non-surgical insemination procedures nation and world-wide. Moving into an administrative leadership position, Christina interacted with multidisciplinary professionals in her role at the Classic Leadership Development Institute.  “With a passion to move forward in the world to promote better unity in social and scientific advancements and change, I landed at cc-TDI and look forward to helping support a team of amazing scientists and engineers into a future of new therapies and scientific discoveries for children with cancer.”

Dina Kats

Dina Kats

Dina Kats joined cc-TDI in January of 2018 to focus on the pediatric liver cancer Hepatoblastoma. Before joining the team, Dina received her bachelor’s degree from UCSD and her Masters in Biology from Northwestern University in Chicago, IL. During her time at Northwestern, Dina focused on developing a tuberculosis vaccine using nanoparticles. In her own words, “I am excited to continue research that will help impact lives with cc-TDI!”

Ken Crawford

Ken Crawford

Ken is a graduate from UC Berkeley where he received a BA in Biology with a emphasis in Cellular Biology. Ken started his career in the SF Bay Area where he worked for a small biotech firm named Chiron Corp, which was later acquired by Novartis Corp.  At Chiron, Ken’s work focused on producing human Growth Factors in yeast for research uses and commercial production.  At Novartis, Ken supported small-molecule drug discovery in many disease areas, but focused on Oncology projects.  Ken has worked on several multidisciplinary projects that developed novels drug therapeutics that are currently in human clinical trials.  These projects include MAPK-, and PI3K-pathway inhibitors for the treatment of cancer.  “I’m excited to join cc-TDI’s vibrant and talented research community and hope to contribute to meeting our shared mission.”

Rishi Rikhi

Rishi Rikhi

Research Student

Rishi is a fourth-year medical student at University of Miami Miller School of Medicine. He grew up in Oregon and graduated from UCLA, with a degree in biology. He joined the Keller laboratory in 2013 as an intern and subsequently researched at cc-TDI as a research volunteer first-class starting in 2015. He has a strong interest in developing targeted therapy for rare pediatric cancers and civic activism to help fund rare pediatric cancers. Rishi has been involved with multiple projects, including rhabdomyosarcoma synthetic lethal drug screen, hepatoblastoma, and epithelioid sarcoma. In addition, Rishi has been a guest lecturer at the 2015 and 2016 nanocourses.

Teagan Settelmeyer

Teagan Settelmeyer

Research Assistant

Teagan recently completed coursework to graduate early from the University of Portland in order to join cc-TDI as a staff scientist this Summer.  Teagan worked in the Keller lab both as a high school student and as a college student … and we’re privileged to have him at cc-TDI full time now.  We see great things ahead for this diligent, inquisitive and hard-working young future physician-scientist!  Teagan enters medical school at Oregon Health & Science University Fall 2016.

Amber Bannon

Amber Bannon

Business Development Intern

Amber joined cc-TDI while pursuing her Ph.D. in Cell and Developmental Biology in the laboratory of Michael Heinrich at Oregon Health & Science University. She studies a subset of Gastrointestinal Stromal Tumors that specifically affects the pediatric population. As a scientist, her goal is to have her lab research be directly translated into clinic. In 2015, she was awarded an OCTRI scholarship aimed at educating graduate students in clinical and translation research. Amber is also enrolled in University of Portland’s Technology Entrepreneurship Program which focuses on commercialization potential and feasibility of bioscience technologies. After graduation, Amber plans to be involved in business development to facilitate the process of turning bench-side experiments into tangible and meaningful results in the clinic.

Matthew Svalina

Matthew Svalina

Senior Research Scientist Emeritus

Matthew Svalina earned a Bachelor of Science degree in Biological Sciences with a minor in Chemistry from the University of Illinois in 2007. Following completion of his undergraduate degree, Matthew earned a paramedic license through Malcolm X College in Chicago, where he completed his field internship with the Chicago Fire Department on ambulances serving the south side of Chicago.

As a member of the Keller lab, Matthew has already co-authored two scientific papers on childhood cancer, with additional studies nearing submission. Under Dr. Keller’s mentorship, Matthew leads basic science and preclinical projects in rhabdomyosarcoma and medulloblastoma. Matthew’s career goal is to be a physician-scientist with training and independent research in neuroscience and neuro-oncology.  Matthew is currently an MD-PhD student at the University of Colorado-Denver.

Ashley Neuenschwander 

Ashley Neuenschwander 

Legal Assistant Intern emeritus

Ashley completed her undergraduate studies at Central Michigan University specializing in Philosophy, Religion, and Psychology. When joining cc-TDI she was working on her Master’s degree at George Washington University in the Paralegal Studies program and looks forward to graduating this spring. In the future Ashley plans to attend law school. She also volunteers as a Court Appointed Special Advocate through local CASA programs. In Ashley’w own words, “my goal is to use my education and experiences to help advocate for the well-being of children.”

Ryan Tormey

Ryan Tormey

Development Intern emeritus

Ryan joined cc-TDI while an undergraduate at American University School of Public Affairs.  He is majoring in Justice, Law & Criminology with a minor in Accounting.  At cc-TDI, Ryan assisted us in Development and Cause Marketing.  

Matthew Randolph, DVM, PhD 

Matthew Randolph, DVM, PhD 

Postdoctoral Fellow emeritus

Dr. Matthew Randolph earned his Doctorate of Veterinary Medicine in 2000 from the University of Georgia College of Veterinary Medicine. He practiced mixed animal medicine as an associate veterinarian in northeast Georgia for five years. Matthew then pursued a career in cancer research and recently trained as a stem cell biologist at Emory University, in the laboratory of Dr. Grace Pavlath, while earning his PhD in Biochemistry, Cell, and Developmental Biology.  He joined cc-TDI in 2015 as a post-doctoral researcher and completed his fellowship February 2017.

Emily Carson 

Emily Carson 

Student Research Intern emeritus 

Emily joined cc-TDI as a junior Biology major at the University of Portland. “I have always been interested in the field of cell and molecular research, and I am very excited about this internship opportunity. In my free time, I enjoy hiking, cooking, reading, and traveling. In the future, I hope to attend Physician’s Assistant School and become a PA in the field of pediatrics.”

Erin Benson

Erin Benson

Advocacy Circle Leader

Erin joined the childhood cancer community in 2013 when her then 2-year-old son, Sam, was diagnosed with DIPG.  In 2014, she launched a nonprofit, WithPurpose, dedicated to advancing treatment for childhood cancer.  WithPurpose has been a partner and supporter of cc-TDI since its inception in 2014.  Prior to becoming a childhood cancer activist, Erin worked as a market research and strategy consultant.  She brought her passion for the mission of making all forms of childhood cancer survivable and her empathy for families in the fight to cc-TDI in 2017.  Erin completed her undergraduate degree at the University of Wisconsin-Madison and her Masters in Communication Studies at the University of Minnesota.

Beckie Lee

Beckie Lee

Development & Partnerships liaison emeritus

Beckie has almost twenty years experience working in development for non-profit organizations, political campaigns and in local government. She is passionate about the work cc-TDI is doing to make childhood cancer universally survivable and is excited to build community support for our work.  Beckie earned a Masters in Public Administration from Portland State University and lives in Northeast Portland with her husband Tim, a Madison High School science teacher, and their daughter Lucy.

Alexis Weyers, JD 

Alexis Weyers, JD 

Operations Director emeritus

Alexis received her undergraduate degree in economics and government from the College of William & Mary in 2006 and her Juris Doctor from the University of Virginia School of Law in 2013.  Prior to joining cc-TDI, Alexis worked as a consultant, tax advisor, law clerk, and lecturer.

Brian Alley

Brian Alley

Master Tinkerer (and research assistant extraordinaire emeritus)

My undergraduate studies in biology as well as the majority of my professional career spent in the fields of microscopy and digital imaging provide a foundation for my ability and desire to contribute to research. However it’s my passion for science, learning, collaborating on big ideas- and the heartfelt belief that there’s plenty of room in this world for positive change- that brought me to cc-TDI. Every day presents a new challenge and I’m humbled to part of such a smart, energized, and creative team that meets these challenges with immediacy and laser focus. It’s a team that does not get discouraged. I hope to make a big difference in the place that makes a big difference in saving kids’ lives. 

Board of Directors

Sunit Rikhi 

Sunit Rikhi 

Board of Directors

Sunit Rikhi is a semiconductor industry executive with over thirty five years of experience. In May 2015, Sunit retired from a 30 year career with Intel as Vice President and General Manager of Intel Custom Foundry. In 2008, he started this business unit from scratch to provide leading edge custom silicon manufacturing services to fabless design companies. At the time he left Intel, the business unit had over a thousand engineers spread across the globe and on a path to ramping volume to over a billion dollars of revenue run rate from over ten customers in the USA and Asia.

Between 2002 and 2008, Sunit successfully led the synchronization of advanced designs with Moore’s Law nodes from 65 nanometers (nm) down to 22nm. During this time, Sunit led Intel’s Design-For-Manufacturing initiative and gave shape to a brand new engineering discipline called computational lithography.

From 1994 to 2002, Sunit led the semiconductor industry in revolutionizing manufacturing operations with fully automated 300 millimeters silicon wafer manufacturing factories. Under his leadership, an entire industrial automation system was put in place to establish the gold standard for not only Intel’s global factory network, but also that of the world.

Prior to 1994, Sunit made several engineering management contributions to Intel’s Mask Shop, Intel’s Design Automation, American Microsystems’ Design Automation and Boeing’s 757 program.

Sunit is a graduate of University of Washington (MSEE) and Birla Institute of Technology and Science (BSEE).

Sunit’s focus as board member of cc-TDI:

As member of cc-TDI Executive Board of Directors, Sunit will help the company establish an organizational culture with engineering discipline and results orientation. He will also facilitate the company’s engagement with engineering talent available in the greater Portland area to give shape to our strong belief that new therapies for children’s cancer can be brought to market faster by infusing innovative engineering approaches into bio-medical research and development.

Amy Meiners

Amy Meiners

Board of Directors - Partner, Cumberland Consulting Group 

Amy is a seasoned technology executive with over 15 years of consulting experience.  Amy started her management consulting career at Computer Science Corporation. After working on a project at a pediatric hospital, Amy found her calling and decided to focus solely on the healthcare industry. In 2005 Amy joined Cumberland Consulting Group based out of Nashville, TN and is now a partner with the firm. She enjoys working with clients to introduce new technology and transforming the delivery of patient care across the country. Her clients range from community hospitals to national healthcare systems in the acute, ambulatory and PALTC space.

Amy became a passionate childhood and young adult cancer advocate after her beloved husband, Matthew, was diagnosed with stage IV alveolar rhabdomyosarcoma in 2007 at the age of 29. Throughout his 8 year-long battle with cancer, Amy was his primary caregiver and patient advocate. Determined to learn everything she could about this horrible disease, Amy became an active member of the research community. She explored every cutting edge option to save her best friend’s life. Throughout their journey, Matthew and Amy experienced the up’s and down’s of fighting cancer which included triumphant periods of remission as well as heartbreaking relapses. Matthew earned his angel wings on July 13, 2015. He fought courageously until the very end and always challenged his clinical team to push the scientific envelope with the hopes of finding a cure. Amy is honored to be a member of the CC-TDI Board. She will proudly carry the torch in Matthew’s memory and share his legacy with anyone who will listen.

Amy’s focus as a CC-TDI Board Member:

As a member of the Executive Board of Directors, Amy will ensure that CC-TDI’s scientific initiatives are in line and stay true to the population for which it serves by representing the children and young adults fighting cancer and their families.

Matt Meiners 

Matt Meiners 

Board of Directors emeritus (see also Matthew's Honor Page)

Matt Meiners started his career in management consulting working for Computer Sciences Corporation. After two years at CSC, he decided to attend law school to pursue his true passion of working in the sports industry. Over the past 10 years, Matt has held various front office positions in the NBA, most recently working for the 2014 NBA Champion San Antonio Spurs. Currently, he is focusing his energy on cancer advocacy. As a three-time rhabdomyosarcoma survivor, Matt brings the important patient perspective to the cc-TDI Board of Directors and is excited to help lead the charge in fighting pediatric and young adult cancer.  

Matt received his undergraduate business degree from the University of Wisconsin and a juris doctorate from Southwestern Law School. He currently resides in San Antonio, TX with his wife, Amy who is also an active member of the research community and an advocate for children, adolescents and young adults with cancer.

Eric C. Jackson 

Eric C. Jackson 

Board of Directors emeritus -  CEO (retired), Peterbilt of Utah 

In 1977 Eric C. Jackson purchased his first dealer franchise in Salt Lake City, Utah.  Since then our dealer group has expanded to 4 states and 14 full service locations.

Eric C Jackson was born into a Quaker family in Oklahoma and grew up on a cattle and farming ranch. He was educated at Central Oklahoma State University at Edmond, Oklahoma. He also attended some advanced courses at Pepperdine University and JF Kennedy University in California.

Eric began his career with Ryder Trucks and was chosen the “Rookie of the Year” during his first year of work. He ended his career at Ryder 7 years later while running the Northern California Divisions which included 14 stores. He left Ryder to become General Manager of Jensen’s Inc., a privately owned family conglomerate located in Fairview Oklahoma.

After two years at Jensen’s, General Motors offered Eric an opportunity to purchase a small GMC store in Salt Lake City. The purchase was completed in July of 1977. This business has grown into the companies that exist today.

Eric was chosen 1996 Entrepreneur of the Year for Utah. He has served on many boards, started over 50 different companies, and sold over 60,000 trucks in his career over the Western United States. Eric is married for 41 years to M. Kaye Jackson and has six grown children and 16 grandchildren.

Eric teaches at the BYU Center for Entrepreneurs on a regular basis. He is a runner, hiker, climber, water skier, and world traveler.

Eric recently returned from a mission with his wife Kaye for the Church of Jesus Christ of Latter Day Saints in the Johannesburg South Africa Mission.  Eric and Faye have ongoing humanitarian service interests across the African continent. 

Atiq Bajwa 

Atiq Bajwa 

Board of Directors, Executive Director - Intel Vice President and General Manager of product architecture (retired)    

Atiq Bajwa is a computing industry executive with over thirty years of technical and executive leadership experience in product research and development. In 2016 he retired from Intel as the Vice President and General Manager of product architecture, responsible for the architectural definition and development of microprocessors for Intel’s ultramobile, PC, workstation and server computing segments.

  

Atiq previously held various technical and management positions in microprocessor development as well as development of electronic design automation (EDA) software used to design Intel CPUs. He also served as General Manager of Intel’s cable networking operation; and led the acquisition and integration of one of Intel’s largest publicly held acquisitions in the networking and communications arena.

  

Atiq holds six US patents in computer architecture and an Intel Achievement Award for pioneering work on the Pentium Pro processor. Before joining Intel, he worked on the development of the 32000 family of microprocessors at National Semiconductor.

  

Atiq received his bachelor’s and master’s degrees in electrical engineering from Yale University.

Gary Nagamori

Gary Nagamori

Board of Directors - Bioscience Consultant

As a bioscience futurist, Gary joins the cc-TDI Executive Board of Directors to leverage his career experience planning biomedical capital projects, shaping a bio-economic development agency and serving the NIH National Center for Research Resources.  From these experiences, Gary has a perspective how emerging technologies shape scientific organizations, operations and economics.  As a consultant, Gary advises in the planning (and funding) of capital infrastructure necessary to support a diversity of operations engaged in the technology transfer process of biomedical research, development, and manufacturing. 

  

Globally, Gary has consulted in the USA, Canada, Mexico, Japan, Malaysia, China and Australia.  As Vice President, National Director of Biosciences he was the market sector thought leader in Biotechnology and Translational Medicine for one of the largest architecture and engineering firms in the US.  Biotech clients have included Genentech, Amgen and Baxter. Translational Medicine clients have included Mayo Clinic, Stanford School of Medicine and Cedars-Sinai Medical Center. 

  

Gary’s purpose as a cc-TDI Board member is to facilitate the resources, institutional infrastructure and organizational culture necessary to support the cc-TDI scientific research mission.

Raj Bopardikar

Raj Bopardikar

Board of Directors - Data Center Competitive Strategy, Intel

Raj Bopardikar is a high tech industry professional with 20 years of experience. Raj has worked at Intel corporation since 2001 where he has held various positions in technology architecture, planning, marketing, and strategy. Raj presently leads Data Center competitive strategy for the Cloud segment. In his role, Raj leads a cross-organization virtual team consisting of business development managers, strategic planners, architects, technologists, field sales representatives, and financial analysts to define short term and long term competitive response for Data Center business. Raj applies his keen understanding of market trends and competitive dynamic in Enterprise and Cloud Data Centers to influence business strategy and tactics. Raj holds an MBA from UC Berkeley Haas School of Business, and MSEE from Drexel University, Philadelphia.

Cason Carter

Cason Carter

Board of Directors

Cason Carter is Director and Head of Government Affairs at Citadel, one of the most respected and successful investment firms in the world. In this role, he oversees public policy strategies for the firm and advises on legislative matters, political engagement efforts and philanthropic initiatives.

Prior to joining Citadel, Mr. Carter managed government and external affairs at Alliance Resource Partners, where he served as Vice President of Public Affairs and Corporate Counsel. Previously, he served as an Attorney at GableGotwals, where he specialized in complex business litigation and simultaneously served as an elected City Counselor in Tulsa, Oklahoma.

Mr. Carter is an advocate for pediatric cancer research and a Trustee for the Scott Carter Foundation. He received his JD from Georgetown University Law Center and bachelor’s degree from Duke University.

Tommy Pham

Tommy Pham

Board of Directors emeritus - Patent Liaison, Nike

Tommy Pham earned his MBA and technology entrepreneurship certificate after participating in a joint program between University of Portland and Oregon Health & Sciences University. The program involved analyzing several OHSU technologies for commercial feasibility, one of which resulted in his start-up, called Nzumbe. Nzumbe focuses on research designed to accelerate the discovery of breakthrough therapies in challenging diseases such as cancer. In addition to heading up Nzumbe, Tommy works for Nike as a Patent Liaison, where he helps identify and capture new innovation for the company. He attended University of Portland, majoring in biology and minoring in chemistry. At UP, Tommy received two major scholarships, one from the Horatio Alger Association and two from the Ford Family Foundation, that covered most of his expenses. The Ford scholarship paid for about 90 percent of his undergraduate education and 80 percent of his MBA education. Up to 120 students from Oregon and Northern California receive the Ford Scholarship per year and about 100 students per year nationwide receive the Horatio Alger Scholarship.